These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24452363)

  • 1. miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood.
    Ries J; Vairaktaris E; Agaimy A; Kintopp R; Baran C; Neukam FW; Nkenke E
    Oncol Rep; 2014 Mar; 31(3):1429-36. PubMed ID: 24452363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in miRNA expression patterns in whole blood of OSCC patients.
    Ries J; Vairaktaris E; Kintopp R; Baran C; Neukam FW; Nkenke E
    In Vivo; 2014; 28(5):851-61. PubMed ID: 25189899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of altered miRNA expression in whole blood of OSCC patients.
    Ries J; Baran C; Wehrhan F; Weber M; Neukam FW; Krautheim-Zenk A; Nkenke E
    Oncol Rep; 2017 Jun; 37(6):3467-3474. PubMed ID: 28498442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The altered expression levels of miR-186, miR-494 and miR-3651 in OSCC tissue vary from those of the whole blood of OSCC patients.
    Ries J; Baran C; Wehrhan F; Weber M; Motel C; Kesting M; Nkenke E
    Cancer Biomark; 2019; 24(1):19-30. PubMed ID: 30594916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by
    Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F
    Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
    Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
    Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
    Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
    Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
    Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
    Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
    He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
    Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
    Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miR-187* is a potential biomarker for oral carcinoma.
    Liu CJ; Lin JS; Cheng HW; Hsu YH; Cheng CY; Lin SC
    Clin Oral Investig; 2017 May; 21(4):1131-1138. PubMed ID: 27324473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
    Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
    BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients.
    Sun L; Liu L; Fu H; Wang Q; Shi Y
    Med Sci Monit; 2016 Jan; 22():289-94. PubMed ID: 26813876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study.
    Nakashima H; Yoshida R; Hirosue A; Kawahara K; Sakata J; Arita H; Yamamoto T; Toya R; Murakami R; Hiraki A; Shinohara M; Ito T; Kuwahara Y; Nakayama H
    Tumour Biol; 2019 Mar; 41(3):1010428319826853. PubMed ID: 30887897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
    Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.